Clinical Trial

Provocation After Nurse-Directed Assessment (PANDA) Study

Study acronym: PANDAS
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-10; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2026-04-28
Trial Details
NCT Number NCT07127835
Lead Sponsor The University of Hong Kong
Conditions Drug Allergy, Penicillin Allergy
Enrollment 440 participants
Start Date 2025-09-01
Primary Completion 2027-08-31 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29